Throughout life, old bone is constantly removed (resorption) and replaced by new bone (formation). This continual process is essential for the maintenance of healthy bone mass and micro-architecture. Accelerated bone mass resorption can occur to women in postmenopausal years. Osteoporosis is a disease characterised by low bone density and reduced structural strength of the bone, leading to increased risk of bone fracture. Osteoporosis affects approximately 30% of postmenopausal women in the US and Europe.1 Around the world 1 in 3 women and 1 in 5 men are at risk of osteoporotic fracture.1

Changes in bone turnover can be assessed by using the comprehensive IDS bone turnover test panel, which offers laboratories an in-vitro alternative to ex-vivo and in-vivo methods. Use of IDS bone turnover assays, enables clinicians to quantify bone formation and resorption levels in order to assist with monitoring.

1. www.iofbonehealth.org

Bone Metabolism Immunoassays

Portfolio Certification Clinical Area Product Type RUO/IVD
CTX-I (CrossLaps®)

CE Marked
FDA Cleared

Automated IVD
Intact PINP

CE Marked

Automated IVD
N-MID® Osteocalcin

CE Marked

Automated IVD
Ostase® BAP

CE Marked
FDA Cleared

Automated IVD
TRAcP 5b (BoneTRAP®)

CE Marked

Automated IVD
Alpha CrossLaps® (CTX-I) EIA

CE Marked
FDA Cleared

Manual IVD
BoneTRAP® (TRAcP 5b) ELISA

CE Marked

Manual IVD
Ostase® BAP EIA

CE Marked
FDA Cleared

Manual IVD
N-MID® Osteocalcin ELISA

CE Marked
FDA Cleared

Manual IVD
Serum Crosslaps® (CTX-I) ELISA

CE Marked
FDA Cleared

Manual IVD
Urine BETA CrossLaps® (CTX-I) ELISA

FDA Cleared

Manual IVD
Urine CrossLaps® (CTX-I) EIA

CE Marked

Manual IVD

Search products

Keyword Search

You can use the keyword search to get results based on specific words or phrases relating to your chosen product

Get In Touch